Renal Survival and Treatment of Adult Patients with Primary Focal Segmental Glomerulosclerosis
Author Information
Author(s): Marinaki Smaragdi, Kompotiatis Panagiotis, Michelakis Ioannis, Stangou Maria, Papagianni Aikaterini, Koukoulaki Maria, Zerbala Synodi, Xydakis Dimitrios, Kaperonis Nikolaos, Dounousi Evangelia, Golfinopoulos Spyridon, Stefanidis Ioannis, Paikopoulou Aggeliki, Moustakas George, Stylianou Kostas, Tzanakis Ioannis, Papasotiriou Marios, Goumenos Dimitrios, Andrikos Aimilios, Kriki Pelagia, Panagoutsos Stylianos, Kiousi Eva, Grapsa Eirini, Koutroumpas Georgios, Pateinakis Panagiotis, Papadopoulou Dorothea, Liakopoulos Vasilios, Bacharaki Dimitra, Kouki Penelope, Petras Dimitrios, Bamichas Gerasimos, Boletis Ioannis
Primary Institution: Department of Nephrology, Laiko General Hospital, National and Kapodistrian University, Athens, Greece
Hypothesis
The study aimed to describe a large cohort of patients with primary FSGS, identify risk factors associated with worse renal survival, and assess the impact of different immunosuppressive regimens on renal survival.
Conclusion
In primary FSGS, complete and partial remission were associated with improved renal survival.
Supporting Evidence
- Complete remission was achieved in 35.5% of patients.
- Partial remission was achieved in 43% of patients.
- Patients who received immunosuppression had a higher percentage of complete remission compared to those who did not.
Takeaway
This study looked at a lot of patients with a kidney disease called FSGS and found that if they got better, their kidneys worked better for longer.
Methodology
This was a historical cohort study of adults diagnosed with primary FSGS from March 26, 1982, to September 16, 2020, analyzing clinical and laboratory parameters.
Potential Biases
Potential misclassification of patients as having primary FSGS due to the long study timeframe.
Limitations
The study did not include histological parameters and lacked data on the duration of immunosuppressive therapy.
Participant Demographics
Mean age was 46 years, with 65% males.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CIs 0.003–0.22 for complete remission; 95% CIs 0.13–0.61 for partial remission.
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website